Surgical staplers market to reach US$7.29 billion by 2029
The global surgical staplers market is projected to reach US$7.29 Billion by 2029 from US$5.15 billion in 2024 at a compound annual...
top of page
Browse by category
Search
Allurion launches AllurionMeds first AI-native compounded GLP-1 program
Allurion Technologies has launched AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss...
Laekna and Eli Lilly to develop ActRIIA antibody for muscle-preserving weight loss in obesity
Laekna Therapeutics has entered a clinical collaboration with Eli Lilly to accelerate the development of LAE102, a novel Activin Receptor...
GT Metabolic Solutions carries out the first magnetic compression anastomosis cases in the US with the linear magnet technology - the MagDI System
GT Metabolic Solutions has completed the first magnetic compression anastomosis cases in the US using the MagDI System, the procedures...
Endevica Bio spins off new company Abisati to develop weight loss drug
Endevica Bio is to spin-off of a newly created company called Abisati to develop an oral weight loss treatment that has shown efficacy in...
GT Metabolic's MagDI System for side-to-side DI anastomosis to "revolutionise industry" after FDA approval
GT Metabolic Solutions has received FDA clearance of its MagDI System for side-to-side duodeno-ileal (DI) anastomosis. The MagDI System...
FDA grants De Novo approval for Distalmotion’s Dexter Surgical Robot for adult inguinal hernia repair
Distalmotion has been granted De Novo approval by the FDA to market the Dexter Surgical Robot for adult inguinal hernia repair. This...
Allurion submits 1st of three PMA modules to FDA
Allurion Technologies has submitted the first three modules of its premarket approval application (PMA) to the FDA for the Allurion...
FDA approves labelling update for VIVUS’ QSYMIA
The FDA has approved a labelling update for VIVUS’ QSYMIA (phentermine and topiramate extended-release capsules CIV) that has removed the...
Phenomix Sciences and InformedDNA enter partnership to advance genetics-driven obesity care
Phenomix Sciences has formed a new partnership to advance precision medicine in obesity with InformedDNA, that integrates Phenomix’s...
Browse by tag
bottom of page